Invitae Spinal Muscular Atrophy STAT Panel
Test analyzes SMN1 copy number to diagnose SMA and reports SMN2 copies when SMN1 is deleted. A rapid 4-day STAT TAT supports urgent treatment decisions.
Accessed through the SMA Identified Sponsored Testing Program•Sponsored by Biogen•Performed by Invitae | Labcorp
Designed to help patients understand the purpose of testing and what to expect.
For patients
What this test and program do
The SMA Identified program provides no-charge genetic testing to support diagnosis of spinal muscular atrophy (SMA) or identify SMA carrier status. Three testing options aim to meet different clinical needs, and results may guide discussions about treatment readiness. Biogen supports the program financially but does not receive any identifiable patient information.
Who this may help
Could this be right for you or your family?
- Patients in the US and Puerto Rico may qualify if they have a suspected diagnosis of spinal muscular atrophy (SMA) or a family history of SMA. Eligibility includes individuals who:
- Are suspected of having SMA or were diagnosed with SMA but do not know their SMN2 copy number
- Are undiagnosed but have a family history of SMA
- Are a first-degree relative of someone diagnosed with SMA through genetic testing
What to expect
How the process works
- 1
Start Order
Discuss testing with your provider and give consent. Your provider will place the order through Invitae’s online portal.
- 2
Provide Sample
Use the Invitae collection kit to submit your sample. Most US shipments can be returned at no additional charge using the provided label.
- 3
Get Results
View your results online. Your provider will review them with you and discuss next steps.
Cost & coverage
Understanding potential costs
If you qualify for this program, the sponsor works with the laboratory to help make testing more affordable. Many patients pay little or no out-of-pocket cost. Your exact cost will depend on your insurance coverage and the specific criteria of the program, and the lab can explain what to expect before your sample is processed.
Quality & privacy
How your sample and information are handled
Testing is performed by Invitae | Labcorp, a CLIA-certified laboratory (CLIA 05D2040778). Your sample is processed using validated methods and quality controls to support reliable genetic results.
Your health information is handled under privacy and security practices that are intended to align with applicable regulations. For program- and lab-specific details, review the privacy information provided by the laboratory and sponsor.
FAQ
Common questions about this program
What is the SMA Identified program?
It’s a no-charge genetic testing program that helps diagnose spinal muscular atrophy (SMA) or identify carrier status when SMA is suspected or runs in the family.
Who is eligible?
Individuals in the US and Puerto Rico with a suspected or confirmed diagnosis of SMA, a family history of SMA, or a first-degree relative recently diagnosed through SMA genetic testing.
Which test is performed?
Testing focuses on SMN1 to detect SMA and reports SMN2 copy number when relevant. Your provider will determine the most appropriate test option offered through this program.
How long does testing take?
Most results are available within 4 days for the STAT assay (SMN1/SMN2 copy number) or standard turnaround for other test options.
Do I have to use a specific SMA therapy if I test through this program?
No. Testing does not obligate you to use any treatment or product. Results may help support clinical decision-making but do not guarantee treatment access.
Questions to ask your doctor about Invitae Spinal Muscular Atrophy STAT Panel
- Do you think this test is appropriate for me based on my symptoms and history?
- How could the results of this test change my diagnosis or treatment plan?
- What are the potential limitations of this test that I should understand?
- Should any of my family members also be tested based on my results?
- How will we follow up after the results are available?
Notes
See an issue with this program?